Lifecore Biomedical, Inc. (LFCR)Healthcare | Drug Manufacturers - Specialty & Generic | Chaska, United States | NasdaqGS
5.20 USD
-0.15
(-2.804%) ⇩
(April 21, 2026, 11:16 a.m.
EDT)
Short-term: ★★★☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 18, 2026, 10:22 p.m. EDT
Fundamentals are in freefall with negative earnings, a massive debt-to-equity ratio over 400%, and a negative P/B value, classifying this as a deep value trap. The short-term technical recovery is fading (down 24% from 52-week highs) with catastrophic statistical confidence in forecasts, making any bounce a contrarian trap rather than a momentum play. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.340154 |
| MSTL | 0.397116 |
| AutoETS | 0.405471 |
| AutoTheta | 0.410212 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 41% |
| H-stat | 38.32 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.055 |
| Excess Kurtosis | -1.61 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 414.803 |
| Revenue per Share | 3.464 |
| Market Cap | 194,882,384 |
| Forward P/E | -6.27 |
| Beta | 0.88 |
| Profit Margins | -23.78% |
| Previous Name | Landec Corporation |
| Website | https://www.lifecore.com |
As of April 18, 2026, 10:22 p.m. EDT: Speculative positioning is inconsistent and low-volume. For both calls and puts at near-term (June) expirations, the overwhelming Open Interest (OI) concentrates heavily on the 7.5 strike (~39% distance from current price), creating a long gamma 'wall' that suggests neutral speculation but poor directional edge. The lack of OTM volume in the immediate calls (May) and the bearish skew in the June OTM puts slightly favors downside protection, yet the sheer absence of directional volume (only 4 OTM call vols vs 51 OTM put vols in June) indicates a lack of active conviction on either side.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.13430423 |
| Address1 | 3,515 Lyman Boulevard |
| All Time High | 20.75 |
| All Time Low | 1.51 |
| Ask | 6.68 |
| Ask Size | 2 |
| Audit Risk | 10 |
| Average Daily Volume10 Day | 357,920 |
| Average Daily Volume3 Month | 310,440 |
| Average Volume | 310,440 |
| Average Volume10Days | 357,920 |
| Beta | 0.878 |
| Bid | 3.86 |
| Bid Size | 2 |
| Board Risk | 4 |
| Book Value | -0.379 |
| City | Chaska |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 5 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 5.2 |
| Current Ratio | 3.491 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 5.39 |
| Day Low | 5.2 |
| Debt To Equity | 414.803 |
| Display Name | Lifecore Biomedical |
| Earnings Call Timestamp End | 1,773,691,200 |
| Earnings Call Timestamp Start | 1,773,691,200 |
| Earnings Timestamp | 1,773,664,200 |
| Earnings Timestamp End | 1,778,011,200 |
| Earnings Timestamp Start | 1,778,011,200 |
| Ebitda | 8,242,287 |
| Ebitda Margins | 0.06366 |
| Enterprise To Ebitda | 45.203 |
| Enterprise To Revenue | 2.878 |
| Enterprise Value | 372,579,008 |
| Eps Current Year | -0.86 |
| Eps Forward | -0.83 |
| Eps Trailing Twelve Months | -1.27 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 5.7448 |
| Fifty Day Average Change | -0.5448003 |
| Fifty Day Average Change Percent | -0.094833635 |
| Fifty Two Week Change Percent | -13.430423 |
| Fifty Two Week High | 8.98 |
| Fifty Two Week High Change | -3.7799997 |
| Fifty Two Week High Change Percent | -0.4209354 |
| Fifty Two Week Low | 3.63 |
| Fifty Two Week Low Change | 1.5699997 |
| Fifty Two Week Low Change Percent | 0.4325068 |
| Fifty Two Week Range | 3.63 - 8.98 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 824,394,600,000 |
| Float Shares | 19,835,281 |
| Forward Eps | -0.83 |
| Forward P E | -6.26506 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 400 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,775,001,600 |
| Gross Margins | 0.31367 |
| Gross Profits | 40,609,720 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01921 |
| Held Percent Institutions | 0.76445 |
| Implied Shares Outstanding | 37,477,386 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Industry Disp | Drug Manufacturers - Specialty & Generic |
| Industry Key | drug-manufacturers-specialty-generic |
| Ir Website | http://landec.com/investor/stock-information/ |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota. |
| Long Name | Lifecore Biomedical, Inc. |
| Market | us_market |
| Market Cap | 194,882,384 |
| Market State | REGULAR |
| Max Age | 86,400 |
| Message Board Id | finmb_30668 |
| Most Recent Quarter | 1,767,139,200 |
| Name Change Date | 2,026-04-20 |
| Net Income To Common | -34,503,432 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 200,504,015 |
| Number Of Analyst Opinions | 3 |
| Open | 5.39 |
| Operating Cashflow | 12,565,716 |
| Operating Margins | 0.08180001 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Peg Ratio | 2.66 |
| Phone | 952 368 4300 |
| Prev Name | Landec Corporation |
| Previous Close | 5.35 |
| Price Eps Current Year | -6.046511 |
| Price Hint | 2 |
| Price To Book | -13.720316 |
| Price To Sales Trailing12 Months | 1.5052948 |
| Profit Margins | -0.23783001 |
| Quick Ratio | 2.176 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.1500001 |
| Regular Market Change Percent | -2.8037403 |
| Regular Market Day High | 5.39 |
| Regular Market Day Low | 5.2 |
| Regular Market Day Range | 5.2 - 5.39 |
| Regular Market Open | 5.39 |
| Regular Market Previous Close | 5.35 |
| Regular Market Price | 5.2 |
| Regular Market Time | 1,776,784,598 |
| Regular Market Volume | 101,472 |
| Revenue Per Share | 3.464 |
| Sand P52 Week Change | 0.34445214 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 7 |
| Shares Outstanding | 37,477,386 |
| Shares Percent Shares Out | 0.0691 |
| Shares Short | 2,591,476 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 2,730,649 |
| Short Name | Lifecore Biomedical, Inc. |
| Short Percent Of Float | 0.120799996 |
| Short Ratio | 5.49 |
| Source Interval | 15 |
| State | MN |
| Symbol | LFCR |
| Target High Price | 9.0 |
| Target Low Price | 5.0 |
| Target Mean Price | 6.5 |
| Target Median Price | 5.5 |
| Total Cash | 17,469,000 |
| Total Cash Per Share | 0.466 |
| Total Debt | 141,282,000 |
| Total Revenue | 129,464,592 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.27 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 7.11975 |
| Two Hundred Day Average Change | -1.9197502 |
| Two Hundred Day Average Change Percent | -0.26963732 |
| Type Disp | Equity |
| Volume | 101,472 |
| Website | https://www.lifecore.com |
| Zip | 55,318 |